July 19 (Reuters) - Zhejiang Hisun Pharmaceutical Co., Ltd. : * Says it signs $3 million technology transfer agreement with Nascent Biotech, Inc, to get exclusive right for Pritumumab, a targeted ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback